Neurology
1 Dec 2024
Real-World Data Sheds Light on Alzheimer’s Biomarker Strategies
Accurately diagnosing Alzheimer’s disease (AD) may soon become more efficient, thanks to a novel biomarker assessment strategy leveraging cerebrospinal fluid (CSF) and PET imaging data, according to a 10-year study conducted at university memory clinics in Europe.